PubMed:10100568
Annnotations
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":51,"end":62},"obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome.\nA 6-year-old girl underwent allogeneic BMT from a matched sibling donor for the treatment of Kostmann syndrome. She suddenly became drowsy on day 30 after BMT, and lost consciousness 2 days later. Cranial CT scan showed symmetrical lesions suggesting bilateral necrosis in the basal ganglia. Clinical and laboratory investigations failed to reveal any evidence of neurometabolic disease."}
PubCasesORDO
{"project":"PubCasesORDO","denotations":[{"id":"AB1","span":{"begin":207,"end":224},"obj":"ORDO:99749"},{"id":"TI1","span":{"begin":95,"end":112},"obj":"ORDO:99749"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome.\nA 6-year-old girl underwent allogeneic BMT from a matched sibling donor for the treatment of Kostmann syndrome. She suddenly became drowsy on day 30 after BMT, and lost consciousness 2 days later. Cranial CT scan showed symmetrical lesions suggesting bilateral necrosis in the basal ganglia. Clinical and laboratory investigations failed to reveal any evidence of neurometabolic disease."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":51,"end":62},"obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome.\nA 6-year-old girl underwent allogeneic BMT from a matched sibling donor for the treatment of Kostmann syndrome. She suddenly became drowsy on day 30 after BMT, and lost consciousness 2 days later. Cranial CT scan showed symmetrical lesions suggesting bilateral necrosis in the basal ganglia. Clinical and laboratory investigations failed to reveal any evidence of neurometabolic disease."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":113},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":114,"end":225},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":226,"end":310},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":311,"end":405},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":406,"end":501},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":113},"obj":"Sentence"},{"id":"T2","span":{"begin":114,"end":225},"obj":"Sentence"},{"id":"T3","span":{"begin":226,"end":310},"obj":"Sentence"},{"id":"T4","span":{"begin":311,"end":405},"obj":"Sentence"},{"id":"T5","span":{"begin":406,"end":501},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome.\nA 6-year-old girl underwent allogeneic BMT from a matched sibling donor for the treatment of Kostmann syndrome. She suddenly became drowsy on day 30 after BMT, and lost consciousness 2 days later. Cranial CT scan showed symmetrical lesions suggesting bilateral necrosis in the basal ganglia. Clinical and laboratory investigations failed to reveal any evidence of neurometabolic disease."}
PubmedHPO
{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":246,"end":252},"obj":"HP_0002329"},{"id":"T2","span":{"begin":375,"end":404},"obj":"HP_0012128"}],"text":"Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome.\nA 6-year-old girl underwent allogeneic BMT from a matched sibling donor for the treatment of Kostmann syndrome. She suddenly became drowsy on day 30 after BMT, and lost consciousness 2 days later. Cranial CT scan showed symmetrical lesions suggesting bilateral necrosis in the basal ganglia. Clinical and laboratory investigations failed to reveal any evidence of neurometabolic disease."}